PROVIDER PROFILE · NPI 1932108263

Mark Leibenhaut

Radiation OncologySacramento, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

—

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Omeprazole13 claims

Pravastatin Sodium13 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Mark Leibenhaut's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Harvey Wolkov Radiation Oncology · Sacramento, CA	193	6,305
ANDRAS, ELLIS	79	354
Ucsf Dermatopathology Service Clinical Laboratory · San Francisco, CA	68	157
Brian Goldsmith Radiation Oncology · Sacramento, CA	24	511
SUPLICA, JEFFREY	19	500
Nitin Rohatgi Hematology · Sacramento, CA	16	93
BISSELL, KAREN	15	27
Brian Golden Urology · Sacramento, CA	13	127
POUNDS, THOMAS	12	25

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history